Regeneron Pharmaceuticals Inc (REGN)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
revenue Increased substantially at the company all along the April to June 30 2023 interval
Regeneron Pharmaceuticals Inc. Dominates Market Growth with Exhilarating Q1 Profits Surge
Earnings down on soft Revenue at the all along the July to September 30 2022 three months
Sharp fall in EPS at the Regeneron Pharmaceuticals Inc in the second quarter of 2022
Very dynamic growth by REGN over the fiscal first quarter of 2022